within Pharmacolibrary.Drugs.ATC.A;

model A02BX04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.3333333333333333,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Methiosulfonium chloride is a synthetic compound that was historically used for the treatment of peptic ulcer disease and gastric hyperacidity. It acts as a gastric acid suppressant, although its precise mechanism of action is not fully elucidated. The drug is largely obsolete and not in clinical use today; it is not found in current therapeutic guidelines, and its approval status has lapsed in most regions.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies specifically reporting parameters for methiosulfonium chloride in humans or animals could be identified.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BX04;
